SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-069382
Filing Date
2021-05-19
Accepted
2021-05-19 16:56:39
Documents
15
Period of Report
2021-05-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2116931d1_8k.htm   iXBRL 8-K 45150
2 EXHIBIT 10.1 tm2116931d1_ex10-1.htm EX-10.1 58489
3 EXHIBIT 10.2 tm2116931d1_ex10-2.htm EX-10.2 33975
4 EXHIBIT 10.3 tm2116931d1_ex10-3.htm EX-10.3 34280
  Complete submission text file 0001104659-21-069382.txt   385762

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vygr-20210514.xsd EX-101.SCH 3220
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20210514_lab.xml EX-101.LAB 34592
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20210514_pre.xml EX-101.PRE 22733
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2116931d1_8k_htm.xml XML 3489
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 21940982
SIC: 2836 Biological Products, (No Diagnostic Substances)